EP2567709
Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.10.2008EP published:
27.12.2017EP application number:
12188230.2
EPO information:
European Patent Register
Max expiry date:
30.10.2028
Title:
Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
Timeline
Today
31.10.2008EP application
27.12.2017EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Cong, FengAddress:
Quincy, MA, US
Name:
Rangwala, Shamina M.Address:
Brookline, MA, US
Name:
Ettenberg, SethAddress:
Melrose, MA, US
Name:
Guth, SabineAddress:
Basel, CH
Priority
Number:
984827 PDate:
2.11.2007Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, C07K 16/28